Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

Healthcare Medical Devices
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Medx Health Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Dojitrader15on Jun 11, 2016 12:53am
55 Views
Post# 24956891

RE:Research coverage by major brokerage firm

RE:Research coverage by major brokerage firm

Insightful1so MedX will have to produce newsworthy stories that get into the national papers or business article supplements so that the average investor sees it and calls his/her broker.[/quote wrote:

I don't think you guys understand what I meant. The launch in Canada never made it to my broker, TD waterhouse, nor did it make it to Credential direct. I'm not even talking the big boys. I talking average investors, such as myself did not receive any news in regard to the launch. That's why I was in the dark and could not understand how Insightful knew before the brokerage houses did.

The fact remains that the news from MDx Health and MDX are getting mixed up and as a result this time instead of receiving MDx Health's news by mistake, we simply did not receive the news of the launch on two major trading companies. 

That's not good, and management has to look into this. This will be the 3rd time I've had to call into both, TD and CD to correct them on the error in company news. Insightful, you've even corrected my once before when I reported on the news that I thought was MDX's but was actually MDx's.

We're all on the same side here and I simply want some of the shareholder's concerns to be addressed as they are quite valid from a publicly traded company. I don't know who you guys do your investments through, but did any of you receive this news through your broker? 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities